Baxter International is recalling one lot of 70% Dextrose Injection after stainless steel particles were found in the solution, the third particulate recall to hit a common intravenous product in about a month.
The company issued the announcement Tuesday, and the FDA published it the same day. The affected lot is Y495066, product code 2B0296H, carrying national drug code 0338-0719-06 and an expiration date of July 31, 2027, according to the FDA recall notice. Baxter says it has received no reports of adverse events connected to the issue.
